Phillips T. Danny - 11 Sep 2025 Form 4 Insider Report for Caris Life Sciences, Inc.

Role
Director
Signature
/s/ J. Russel Denton, Attorney-in-Fact
Issuer symbol
CAI on Nasdaq
Transactions as of
11 Sep 2025
Net transactions value
+$244,000
Form type
4
Filing time
12 Sep 2025, 16:29:39 UTC
Previous filing
17 Jun 2025
Next filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PHILLIPS T DANNY Director C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton, Attorney-in-Fact 12 Sep 2025 0001239690

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAI Common Stock Options Exercise $244,000 +100,000 +620% $2.44 116,129 11 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAI Stock Option Options Exercise $0 -100,000 -100% $0.000000 0 11 Sep 2025 Common Stock 100,000 $2.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and exercisable.